Complete Radiopharmaceutical Therapy Solutions

Learn More

Biomarker Discovery with Spatial Resolution

Explore More

Complete Clinical Imaging Core Lab Capabilities

Learn More

Unmatched PSMA-PET Solutions: Advancing the Standard of Care

Learn More

Learn What Invicro's IQ Analytics Platform Can Do

Learn More

Gain New Insights in Early Drug Discovery

Learn More

Attending ASCO 2023?

 

Visit us June 2-6 at #ASCO23 at REALM IDx booth #22135 to learn how our customized cutting-edge solutions support all imaging aspects of your Phase 0-IV clinical trials. Discover how Invicro can transform your global clinical oncology research:

 

 

Schedule a Meeting

Supporting >75% of RPT Programs

 

Development of radiopharmaceutical therapies & theranostics is a challenging process that requires close collaboration with experts. Learn what industry leaders are saying about radiopharmaceutical therapy development by exploring Invicro’s latest webinars, case studies, expert interviews and more.

Access Resources

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY
EARLY
CLINICAL
LATE
PHASE
  • 3,500+ Research Trials Managed
  • 535+ Clinical Trials Managed
  • 40,000,000+ (DICOM) Images Processed
  • 800+ Molecules Labeled

CNS Webinar Series

Discover our capabilities from in vitro assays to in vivo imaging using PET, SPECT and MRI imaging biomarkers in CNS drug development and CNS clinical trials.

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late-phase oncology studies.

Watch Now